Beyer, 2024 - Google Patents

From Radiochemistry of the Lanthanides to 225Ac and the Interference with Richard Baum

Beyer, 2024

View HTML
Document ID
160382565170364998
Author
Beyer G
Publication year
Publication venue
Beyond Becquerel and Biology to Precision Radiomolecular Oncology: Festschrift in Honor of Richard P. Baum

External Links

Snippet

Abstract In 1990, Heinz Schelbert, one of the pioneers of PET, has been asked during an invited lecture at the ZfK Rossendorf, why it happens that few newly created PET centers have significant success and others do not have at all. His answer was simple and clear …
Continue reading at link.springer.com (HTML) (other versions)

Classifications

    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/04Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
    • G21G1/10Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by bombardment with electrically charged particles
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G4/00Radioactive sources
    • G21G4/04Radioactive sources other than neutron sources
    • G21G4/06Radioactive sources other than neutron sources characterised by constructional features
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/04Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators
    • G21G1/06Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes outside nuclear reactors or particle accelerators by neutron irradiation
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001Recovery of specific isotopes from irradiated targets
    • GPHYSICS
    • G21NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21GCONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/0005Isotope delivery systems

Similar Documents

Publication Publication Date Title
Naskar et al. Theranostic terbium radioisotopes: challenges in production for clinical application
McCarthy et al. Efficient production of high specific activity 64Cu using a biomedical cyclotron
Misiak et al. 47Sc production development by cyclotron irradiation of 48Ca
Beyer et al. Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using 149Tb-rituximab
Loveless et al. Photonuclear production, chemistry, and in vitro evaluation of the theranostic radionuclide 47Sc
CA2594829C (en) Method for production of radioisotope preparations and their use in life science, research, medical application and industry
Qaim et al. Development of novel radionuclides for medical applications
Beyer et al. Production routes of the alpha emitting 149Tb for medical application
Fiaccabrino et al. Potential for production of medical radionuclides with on-line isotope separation at the ISAC facility at TRIUMF and particular discussion of the examples of 165Er and 155Tb
Moiseeva et al. Cross section measurements of 151Eu (3He, 5n) reaction: new opportunities for medical alpha emitter 149Tb production
Andrighetto et al. The ISOLPHARM project: ISOL-based production of radionuclides for medical applications
Sadler et al. Cutting edge rare earth radiometals: prospects for cancer theranostics
Qaim Use of cyclotrons in medicine
Srivastava et al. Therapeutic radionuclides: production, physical characteristics, and applications
Stevenson et al. Methods of producing high specific activity Sn-117m with commercial cyclotrons
Chernysheva et al. Accelerator production of scandium radioisotopes: Sc-43, Sc-44, and Sc-47
Kazakov et al. Separation of radioisotopes of terbium from a europium target irradiated by 27 MeV α-particles
Kazakov Terbium isotopes in nuclear medicine: production, recovery, and application
Abel et al. Production, collection, and purification of 47Ca for the generation of 47Sc through isotope harvesting at the national superconducting cyclotron laboratory
Aliev et al. Photonuclear production of medically relevant radionuclide 47Sc
Bernerd et al. Production of innovative radionuclides for medical applications at the CERN-MEDICIS facility
Pupillo et al. The LARAMED project at INFN-LNL: review of the research activities on medical radionuclides production with the SPES cyclotron
Nagai Production scheme for diagnostic-therapeutic radioisotopes by accelerator neutrons
McNeil et al. From cyclotrons to chromatography and beyond: a guide to the production and purification of theranostic radiometals
Vallabhajosula Production of radionuclides